Albinterferon
id:
albinterferon-280-15908910
title:
Albinterferon
text:
Albinterferon is a recombinant fusion protein drug consisting of interferon alpha (IFN-α) linked to human albumin. Conjugation to human albumin prolongs the half-life of the IFN-α to about 6 days, allowing to dose it every two to four weeks. The drug was under investigation as an alternative to pegylated IFN-α-2a for the treatment of hepatitis C. In response to an FDA ruling, Novartis and Human Genome Sciences announced on October 5, 2010 that they will cease development of the drug.
A French ex
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Albinterferon
date created:
date modified:
2023-08-12T09:02:30Z
main entity:
{"identifier":"Q4712444","url":"https://www.wikidata.org/entity/Q4712444"}
image:
fields total:
13
integrity:
14